Medication info

Fluorometholone Eye Drops

Prescription medicationSuspensionEye drops
Ingredient · strength
Fluorometholone›1mg / 1mL
Manufacturer / importer
nexpharm korea, GENUONE Sciences Inc.
Appearance
A colorless to light yellow suspension in a plastic container
Packaging
[Domestic use] 6mL/bottle [Export use] 5mL/bottle, 6mL/bottle
Approval status
Active

MFDS item code 201403510 · Notified 2014.07.30 · Insurance code 671704311

Summary

Main use
Treatment of inflammation of the external and anterior segments of the eye (e.g., conjunctivitis, keratitis, and blepharitis)
Who applies the drops
Adults
Adult eye dose
Instill 1~2 drops into the eye 2~4 times daily. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
nexpharm korea
Manufacturer
GENUONE Sciences Inc.

Efficacy & effects

Treatment of inflammation of the external and anterior segments of the eye (e.g., conjunctivitis, keratitis, and blepharitis)

  • Blepharitis
  • conjunctivitis
  • keratitis
  • scleritis
  • episcleritis
  • iritis
  • cyclitis
  • uveitis
  • post-surgical inflammation
View approved original text

This medication is effective for a variety of inflammatory diseases of the outer eye and anterior segment, ranging from blepharitis (inflammation of the eyelids) to conjunctivitis, keratitis, scleritis, episcleritis, iritis, cyclitis, and uveitis. It also helps treat inflammation that may occur after surgery. This drug is used to relieve eye inflammation and improve symptoms for the recovery of the patient's eye health.

How to apply drops

Adult eye dose

Instill 1~2 drops into the eye 2~4 times daily. Adjust the dose appropriately according to symptoms.

Precautions

This medication should not be used in patients with viral keratitis or conjunctivitis, fungal eye diseases, mycobacterial infections, or chronic blepharitis. Additionally, patients with hypersensitivity to this drug should not receive it. Special caution is needed if the corneal epithelium is damaged or there is a corneal ulcer, as symptoms may worsen. Tuberculous or purulent ocular disease patients should also be cautious when using this drug due to the risk of corneal perforation. It is generally avoided in glaucoma patients and infants under 2 years old. Long-term use may increase the risk of elevated intraocular pressure, glaucoma, and optic nerve damage, thus regular intraocular pressure checks are needed. This drug can increase the risk of infections such as herpes simplex keratitis and fungal keratitis, so if any infection symptoms appear, appropriate treatment must be sought immediately. Rarely, side effects like corneal perforation or cataracts may occur. Long-term use can suppress immune responses, increasing the risk of secondary infections. In cases of acute purulent ocular infections, this drug may mask or worsen symptoms. If inflammation or pain in the eyes persists or worsens for more than 48 hours after administration, discontinue use immediately and consult a physician. Contact lens wearers must remove lenses before instillation and wait at least 30 minutes before re-wearing them. Temporary blurred vision may occur after instillation, so driving or operating hazardous machinery should be avoided. If infected with chickenpox or measles, this drug may be fatal, so it's crucial to verify the patient's medical history and vaccination status and seek medical attention if infection occurs. Children and patients taking CYP3A4 inhibitors may have a higher risk of systemic side effects following use. This drug may increase systemic exposure when used with CYP3A4 inhibitors, thus usage should adhere to a physician's instructions. Pregnant or potentially pregnant women should avoid long-term or frequent use, and breastfeeding mothers should discontinue breastfeeding while using this drug. Safety in children and adolescents has not been established, so caution is warranted. Elderly patients may have a higher risk of adverse effects due to diminished physiological function, requiring special attention. This medication is for ophthalmic use only, and care should be taken to avoid direct contact of the container tip with the eye. Shake the medication well before use and it is advisable to avoid sharing to prevent contamination. When storing, keep it out of the reach of children and store it in a cool place away from direct sunlight.

Side effects

Optic nerve damage, decreased vision, visual field loss, glaucoma, increased intraocular pressure, corneal herpes, corneal fungal infection, Pseudomonas infection, corneal ulcer, corneal perforation, posterior capsule cataract, secondary endophthalmitis, exacerbation of acute purulent endophthalmitis, acute uveitis, keratitis, conjunctivitis, corneal ulcer, mydriasis, conjunctival hyperemia, accommodation paralysis, ptosis, corneal calcification, delayed wound healing, increased vesicle formation, suppression of pituitary-adrenal function, hypersensitivity symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, preferably at a cool room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy over time.

Appearance and packaging

Appearance

A colorless to light yellow suspension in a plastic container

Package unit

[Domestic use] 6mL/bottle [Export use] 5mL/bottle, 6mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.